MeSH tree: D08.811.277.656.300.760.875
For patients with non-large vessel occlusion, acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase administered 4.5 to 24 hours after stroke onset is associated with a higher likelihood of excellent ...
Feb 10, 2026
0
0
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who received a placebo, according ...
Feb 7, 2026
0
0
Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the number of patients who fully recover, according to preliminary late-breaking science presented at ...
Feb 4, 2026
0
0
Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion does not improve vision recovery at 30 days compared with oral aspirin, according to a study published in the Jan. 29 ...
Feb 2, 2026
0
0
Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early Management of Patients ...
Jan 26, 2026
0
0
For more than 40 years as a researcher and clinician, Joseph Broderick has actively contributed to improvements in stroke care, occupying a front row seat to seismic innovations: the clinical trials that proved tPA as the ...
Oct 23, 2025
0
0
Found in everything from protein bars to energy drinks, erythritol has long been considered a safe alternative to sugar. But new research suggests this widely-used sweetener may be quietly undermining one of the body's most ...
Jul 21, 2025
0
27
Research presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting included three studies that explored the differences in treatment and recovery options for patients across racial, gender ...
Jul 14, 2025
0
0
For patients with acute ischemic stroke due to large-vessel occlusion who present within 4.5 hours, intravenous tenecteplase before endovascular thrombectomy is associated with higher functional independence at 90 days, according ...
May 25, 2025
0
0
A new clotbusting drug tested on mice has been shown by University of Manchester scientists to be significantly better at treating ischemic stroke than existing therapies.
Apr 29, 2025
0
0
